PRESS-RELEASE filed Mar 16, 2026 at 07:00 ET
WW International reported Q4 2025 results with total revenue of $162.8 million, down 12% year-over-year, driven by secular declines in its Behavioral business. However, Clinical Subscription Revenue surged 32% YoY to $27 million, with Clinical subscribers up 42% to 130 thousand. The company exceeded 2025 Adjusted EBITDA guidance and provided 2026 revenue guidance of $620–635 million and Adjusted EBITDA of $105–115 million, signaling a strategic shift toward integrated GLP-1 and behavioral health solutions.